Breast cancer staging in population-based registries

an alert to the quality of information

Authors

Keywords:

breast neoplasms, neoplasm staging, registries, evidence-based practice

Abstract

Objective: To discuss the practical difficulties associated with breast cancer staging, especially in the context of population- based cancer registries (PBCR). Methods: This is a short communication that discusses the importance and temporal evolution of breast cancer staging, as well as the limitations and new challenges associated with this process. Results: This study discusses the importance and temporal evolution of breast cancer staging, as well as the limitations and new challenges associated with this process. Minimal divergences in physical examination and disagreements in imaging tests can classify the patient in a higher or lower stage of the disease. In some population-based registries, up to 20% of the information regarding the clinical stage of breast cancer may be mistaken. Conclusion: We highlight the necessity for continuing education and constant training for all professionals involved in the breast cancer epidemiological context. The utilization of new technologies can help standardize the information and reduce the divergences related to cancer staging registry.

Downloads

Download data is not yet available.

Author Biographies

Leonardo Ribeiro Soares, Universidade Federal de Goiás

Mastology Program, Hospital das Clínicas, Universidade Federal de Goiás – Goiânia (GO), Brazil.

Maria Paula Curado, A.C. Camargo Cancer Center

A.C. Camargo Cancer Center, Fundação Antônio Prudente – São Paulo (SP), Brazil.

Ruffo Freitas-Junior, Universidade Federal de Goiás

Mastology Program, Hospital das Clínicas, Universidade Federal de Goiás – Goiânia (GO), Brazil. Hospital Araújo Jorge, Associação de Combate ao Câncer em Goiás – Goiânia (GO), Brazil

References

Beahrs OH. Staging of cancer of the breast as a guide to therapy. Cancer. 1984;53(3 Suppl.):592-4. https://doi.org/10.1002/1097-0142(19840201)53:3+%3C592::aid-cncr2820531303%3E3.0.co;2-9

Chavez-MacGregor M, Mittendorf EA, Clarke CA, Lichtensztajn DY, Hunt KK, Giordano SH. Incorporating Tumor Characteristics to the American Joint Committee on Cancer Breast Cancer Staging System. Oncologist. 2017;22(11):1292-300. https://doi.org/10.1634/theoncologist.2017-0116

Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, et al. AJCC cancer staging manual. 6th ed. New York: Springer-Verlag; 2002.

Curado MP. Techniques of registration. In: Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al., eds. Cancer Incidence in Five Continents. Lyon: IARC; 2007. v. 9. p. 14-39.

Camargo Cancela M, Chapuis F, Curado MP. Abstracting stage in population-based cancer registries: the example of oral cavity and oropharynx cancers. Cancer Epidemiol. 2010;34(4):501-6. https://doi.org/10.1016/j.canep.2010.04.012

Curado MP, Voti L, Sortino-Rachou AM. Cancer registration data and quality indicators in low and middle income countries: their interpretation and potential use for the improvement of cancer care. Cancer Causes Control. 2009;20:751-6. https://doi.org/10.1007/s10552-008-9288-5

Weiss A, Chavez-MacGregor M, Lichtensztajn DY, Yi M, Tadros A, Hortobagyi GN, et al. Validation study of the AJCC eighth edition prognostic stage compared with the anatomic stage in breast cancer. JAMA Oncol. 2018;4(2):203-9. https://doi.org/10.1001/jamaoncol.2017.4298

Valsecchi MG, Steliarova-Foucher E. Cancer registration in developing countries: luxury or necessity? Lancet Oncol. 2008;9(2):159-67. https://doi.org/10.1016/S1470-2045(08)70028-7

Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al. CONCORD Working Group. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385(9972):977-1010. https://doi.org/10.1016/S0140-6736(14)62038-9

Abreu E, Koifman RJ, Fanqueiro AG, Land MGP, Koifman S. Sobrevida de dez anos de câncer de mama feminino em coorte populacional em Goiânia (GO), Brasil, 1988-1990. Cad Saúde Coletiva. 2012;20(3):305-13.

Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008;9(8):730-56. https://doi.org/10.1016/S1470-2045(08)70179-7

Freitas-Junior R, Nunes RD, Martins E, Curado MP, Freitas NMA, Soares LR, et al. Prognostic factors and overall survival of breast cancer in the city of Goiania, Brazil: a population-based study. Rev Col Bras Cir. 2017;44(5):435-43. https://doi.org/10.1590/0100-69912017005003

Allemani C, Coleman MP. Cancer survival: [corrected] the CONCORD-2 study - Authors’ reply. Lancet. 2015;386(9992):429-30. https://doi.org/10.1016/S0140-6736(15)61443-X

Freitas-Junior R, Soares LR, Barrios CH. Cancer survival:[corrected] the CONCORD-2 study. Lancet. 2015;386(9992):428-9. https://doi.org/10.1016/S0140-6736(15)61441-6

Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Instituto Nacional de Câncer. Coordenação de Prevenção e Vigilância. Manual de rotinas e procedimentos para registros de câncer de base populacional. 2nd ed. Rio de Janeiro: INCA; 2012 [accessed on 22 Jan 2019]. Available at: https://www.inca.gov.br/publicacoes/manuais/manual-de-rotinas-e-procedimentos-para-registros-de-cancer-de-base-populacional

Parkin DM, Whelan SI, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents. Lyon: International Agency for Research on Cancer; 2002. v. 8.

Freitas NMA, Freitas-Junior R, Curado MP, Martins E, Bandeira e Silva CM, Moreira MAR, et al. Tendência da incidência e da mortalidade do câncer de mama em Goiânia: análise de 15 anos (1988-2002). Rev Bras Mastol. 2006;16(1):17-21.

Moura L, Curado MP, Simões EJ, Cezário AC, Urdaneta M. Avaliação do registro de câncer de base populacional do município de Goiânia, estado de Goiás, Brasil. Epidemiol Serv Saúde. 2006;15(4):7-17. https://doi.org/10.5123/S1679-49742006000400002

Miller JW, Smith JL, Ryerson AB, Tucker TC, Allemani C. Disparities in breast cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study. Cancer. 2017;123(Suppl. 24):5100-18. https://doi.org/10.1002/cncr.30988

Elkin EB, Hudis C, Begg CB, Schrag D. The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975-1999. Cancer. 2005;104(6):1149-57. https://doi.org/10.1002/cncr.21285

Lemos NAF, Freitas-Junior R, Moreira MAR, Silva TC, Oliveira JC, Silva CMB. Difficulties in collecting data on ductal carcinoma in situ at a population-based cancer registry. Mastology. 2019;29(2):86-9. https://doi.org/10.29289/2594539420190000421

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. Fort Washington: National Comprehensive Cancer Network; 2020 [accessed on Jun. 15, 2020]. Available at: https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf

Tolêdo SRS, Almeida NAM, Souza MR, Minamisava R, Freitas-Junior R. Care flow of breast cancer patients in the public health care network. Rev Eletr Enf. 2016;18:e1201. https://doi.org/10.5216/ree.v18.39147

McCready DR, Yong WS, Ng AK, Miller N, Done S, Youngson B. Influence of the new AJCC breast cancer staging system on sentinel lymph node positivity and false-negative rates. J Natl Cancer Inst. 2004;96(11):873-5. https://doi.org/10.1093/jnci/djh142

Woodward WA, Strom AS, Tucker SL, McNeese MD, Perkins GH, Schechter NR, et al. Changes in the 2003 American Joint Committee on Cancer—staging for breast cancer dramatically affects stage-specific survival. J Clin Oncol. 2003;21(17):3244-8. https://doi.org/10.1200/JCO.2003.03.052

Hortobagyi GN, Connolly JL, D’Orsi CJ, Edge SB, Mittendorf EA, Rugo HS, et al. Breast. In: Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al. AJCC Cancer Staging Manual. 8th ed. New York: Springer; 2016.

Giuliano AE, Edge SB, Hortobagyi GN. Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer. Ann Surg Oncol. 2018;25:1783-5. https://doi.org/10.1245/s10434-018-6486-6

Luen S, Virassamy B, Savas P, Salgado R, Loi S. The genomic landscape of breast cancer and its interaction with host immunity. Breast. 2016;29:241-50. https://doi.org/10.1016/j.breast.2016.07.015

Li X, Zhang Y, Meisel J, Jiang R, Behera M, Peng L. Validation of the newly proposed American Joint Committee on Cancer (AJCC) breast cancer prognostic staging group and proposing a new staging system using the National Cancer Database. Breast Cancer Res Treat. 2018;171:303-13. https://doi.org/10.1007/s10549-018-4832-9

Cardoso F, van’t Veer LJ, Bogaerts J, Slaets L, Viale G, Delaloge S, et al. 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer. N Engl J Med. 2016;375(8):717-29. https://doi.org/10.1056/NEJMoa1602253

Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, et al. Adjuvant Chemotherapy Guided by a

- Gene Expression Assay in Breast Cancer. N Engl J Med. 2018;379(2):111-21. https://doi.org/10.1056/NEJMoa1804710

Andrade WP. TNM8 Breast Cancer Calculator [Internet]. Apple; 2018 [accessed on Jun. 15, 2020]. Available at: https://itunes.apple.com/us/app/tnm8-breast-cancer-calculator/id1294700966?mt=8

Downloads

Published

2021-04-05

How to Cite

Soares, L. R., Curado, M. P., & Freitas-Junior, R. (2021). Breast cancer staging in population-based registries: an alert to the quality of information. Mastology, 31, 1–5. Retrieved from https://revistamastology.emnuvens.com.br/revista/article/view/326

Issue

Section

Short Communications